InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design (vol 11, pg 1017, 2020)

被引：2
|
作者：
Battelino, Tadej [1 ]
Bosnyak, Zsolt [2 ]
Danne, Thomas [3 ]
Mukherjee, Bhaswati [2 ]
Edelman, Steve [4 ]
Pilorget, Valerie [2 ]
Choudhary, Pratik [5 ,6 ]
Renard, Eric [7 ,8 ,9 ]
Bergenstal, Richard [10 ]
机构：
[1] Univ Ljubljana, Fac Med, Univ Childrens Hosp, UMC, Ljubljana, Slovenia
[2] Sanofi SA, Paris, France
[3] Childrens & Youth Hosp Auf Der Bult, Diabet Ctr Children & Adolescents, Hannover, Germany
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Kings Coll Hosp NHS Fdn Trust, London, England
[6] Kings Coll London, Sch Life Course Sci, Dept Diabet, London, England
[7] Univ Montpellier, Montpellier Univ Hosp, Dept Endocrinol Diabet & Nutr, Montpellier, France
[8] Univ Montpellier, Inst Funct Genom, Montpellier, France
[9] INSERM Clin Invest Ctr, Montpellier, France
[10] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA
来源：
DIABETES THERAPY | 2020年 / 11卷 / 07期
关键词：
D O I：
10.1007/s13300-020-00820-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In the original publication, the timing of baseline CGM assessment was incorrectly stated in the text in two instances; it is correct in Fig. 1.
引用
收藏
页码：1607 / 1608
页数：2
相关论文
共 50 条
  • [21] IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES
    Visentin, R.
    Schiavon, M.
    Giegerich, C.
    Sieber, J.
    Man, C. Dalla
    Cobelli, C.
    Klabunde, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A18 - A18
  • [22] Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins (vol 32, pg 2255, 2022)
    Buzzetti, Raffaella
    Fadini, Gian Paolo
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Cucinotta, Domenico
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (04) : 920 - 921
  • [23] Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study
    Yamabe, Mizuho
    Kuroda, Mami
    Hirosawa, Yasuyo
    Kamino, Hiromi
    Ohno, Haruya
    Yoneda, Masayasu
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 352 - 357
  • [24] TERTIARY CGM ENDPOINTS COMPARING SECONDGENERATION BASAL INSULIN ANALOGS GLARGINE 300 U/ML AND DEGLUDEC 100 U/ML IN PEOPLE WITH T1D: INRANGE RANDOMIZED CONTROLLED TRIAL
    Bergenstal, R.
    Edelman, S.
    Choudhary, P.
    Danne, T.
    Renard, E.
    Westerbacka, J.
    Mukherjee, B.
    Coudert, M.
    Pilorget, V.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A53 - A54
  • [25] Insulin glargine 300 U/ml vs 100 U/ml: glucose profiles of morning vs evening injections in adults with type 1 diabetes mellitus measured with continuous glucose monitoring (CGM)
    Bergenstal, R. M.
    Bailey, T. S.
    Rodbard, D.
    Ziemen, M.
    Guo, H.
    Muehlen-Bartmer, I.
    Ahmaan, A. J.
    DIABETOLOGIA, 2014, 57 : S388 - S389
  • [26] Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A  Practical Guide
    Gary Deed
    Roy Rasalam
    Chee Khoo
    Tom Dover
    Nick Forgione
    Diabetes Therapy, 2019, 10 : 1987 - 1994
  • [27] Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A Practical Guide
    Deed, Gary
    Rasalam, Roy
    Khoo, Chee
    Dover, Tom
    Forgione, Nick
    DIABETES THERAPY, 2019, 10 (06) : 1987 - 1994
  • [28] New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
    Matsuhisa, M.
    Koyama, M.
    Cheng, X.
    Takahashi, Y.
    Riddle, M. C.
    Bolli, G. B.
    Hirose, T.
    DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 375 - 383
  • [29] Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial
    Battelino, Tadej
    Danne, Thomas
    Edelman, Steve, V
    Choudhary, Pratik
    Renard, Eric
    Westerbacka, Jukka
    Mukherjee, Bhaswati
    Pilorget, Valerie
    Coudert, Mathieu
    Bergenstal, Richard M.
    DIABETES OBESITY & METABOLISM, 2023, 25 (02): : 545 - 555
  • [30] Evaluation of Patient Reported Satisfaction and Clinical Efficacy of Insulin Glargine 300 U/mL Versus 100 U/mL in Patients With Type 1 Diabetes Using Flash Glucose Monitoring System
    Al Hayek, Ayman Abdullah
    Alwin Robert, Asirvatham
    Al Saeed, Abdulghani H.
    Al Dawish, Mohamed Abdulaziz
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2022, 15
12345